Tags

Type your tag names separated by a space and hit enter

[Clinical evaluation of the use of propoleum in Peyronie's disease].
Arch Esp Urol. 1998 Mar; 51(2):171-6.AE

Abstract

OBJECTIVE

To analyze the clinical efficacy of propoleum in Peyronie's disease.

METHODS

A controlled, double-blind clinical trial based on a previous pilot study was conducted in 34 patients with Peyronie's disease treated with propoleum (Cuban Academy of Sciences patent no. 21875). The study was performed at the Freyre de Andrade Hospital in Habana. The clinical course and ultrasound features of the fibrous plaque were evaluated during a period of 6 months.

RESULTS

A marked improvement was observed for penile curvature and pain in the treated group. Furthermore, plaque consistency and size was reduced five-fold after treatment and two-fold at ultrasound evaluation. No clinical or ultrasound changes were observed in the control group.

CONCLUSIONS

Our results demonstrate the efficacy of propoleum in Peyronie's disease.

Authors+Show Affiliations

Servicio de Urología, Radiología, Hospital de Andrade, Centro Habana, Cuba.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Controlled Clinical Trial
English Abstract
Journal Article

Language

spa

PubMed ID

9586317

Citation

Lemourt Oliva, M, et al. "[Clinical Evaluation of the Use of Propoleum in Peyronie's Disease]." Archivos Espanoles De Urologia, vol. 51, no. 2, 1998, pp. 171-6.
Lemourt Oliva M, Filgueiras López E, Rodríguez Barroso A, et al. [Clinical evaluation of the use of propoleum in Peyronie's disease]. Arch Esp Urol. 1998;51(2):171-6.
Lemourt Oliva, M., Filgueiras López, E., Rodríguez Barroso, A., González Oramas, E., & Bordonado, R. (1998). [Clinical evaluation of the use of propoleum in Peyronie's disease]. Archivos Espanoles De Urologia, 51(2), 171-6.
Lemourt Oliva M, et al. [Clinical Evaluation of the Use of Propoleum in Peyronie's Disease]. Arch Esp Urol. 1998;51(2):171-6. PubMed PMID: 9586317.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Clinical evaluation of the use of propoleum in Peyronie's disease]. AU - Lemourt Oliva,M, AU - Filgueiras López,E, AU - Rodríguez Barroso,A, AU - González Oramas,E, AU - Bordonado,R, PY - 1998/5/20/pubmed PY - 1998/5/20/medline PY - 1998/5/20/entrez SP - 171 EP - 6 JF - Archivos espanoles de urologia JO - Arch Esp Urol VL - 51 IS - 2 N2 - OBJECTIVE: To analyze the clinical efficacy of propoleum in Peyronie's disease. METHODS: A controlled, double-blind clinical trial based on a previous pilot study was conducted in 34 patients with Peyronie's disease treated with propoleum (Cuban Academy of Sciences patent no. 21875). The study was performed at the Freyre de Andrade Hospital in Habana. The clinical course and ultrasound features of the fibrous plaque were evaluated during a period of 6 months. RESULTS: A marked improvement was observed for penile curvature and pain in the treated group. Furthermore, plaque consistency and size was reduced five-fold after treatment and two-fold at ultrasound evaluation. No clinical or ultrasound changes were observed in the control group. CONCLUSIONS: Our results demonstrate the efficacy of propoleum in Peyronie's disease. SN - 0004-0614 UR - https://wwww.unboundmedicine.com/medline/citation/9586317/[Clinical_evaluation_of_the_use_of_propoleum_in_Peyronie's_disease]_ DB - PRIME DP - Unbound Medicine ER -